Vonaday Tablets

Q1: What is Vonaday (Tenofovir + Lamivudine) used for?

Vonaday is a dual NRTI backbone combination of Tenofovir Disoproxil Fumarate 150mg and Lamivudine used as the NRTI foundation in HIV combination therapy. Combined with a third agent (INSTI, NNRTI, or PI), it provides effective HIV-1 suppression.

Q2: How do Tenofovir and Lamivudine work together?

Tenofovir DF (as tenofovir diphosphate) and Lamivudine (as lamivudine triphosphate) both inhibit HIV reverse transcriptase through chain termination. Their synergistic activity at different positions reduces the likelihood of resistance developing to either agent alone.

Q3: How is Vonaday taken?

Take once or twice daily as prescribed, with or without food. Consistent daily timing is critical for maintaining therapeutic drug levels and preventing resistance development. Never stop without consulting your HIV specialist.

Q4: Does Vonaday treat hepatitis B?

Yes. Both Tenofovir DF and Lamivudine have anti-HBV activity. This combination provides dual HIV/HBV suppression in co-infected patients. Never stop Vonaday in HIV/HBV patients without maintaining HBV coverage — stopping risks severe hepatitis flare.

Q5: What are the most common side effects?

Nausea, diarrhea, headache, and fatigue are most common. Long-term Tenofovir DF use can reduce bone mineral density and rarely cause kidney tubular dysfunction — monitoring is important.

Q6: What kidney monitoring is required for Tenofovir?

Serum creatinine, eGFR, phosphate, and urine protein should be checked at baseline and every 6 months during long-term use. Patients with eGFR <30 ml/min should not use TDF-based regimens.

Q7: What serious side effects require emergency care?

Seek immediate care for: lactic acidosis (muscle pain, weakness, breathing difficulty — rare), severe hepatotoxicity (jaundice, dark urine), or HBV flare if the regimen is stopped unexpectedly.

Q8: Can Vonaday be used during pregnancy?

TDF-based dual NRTI combinations have been extensively studied in pregnancy and are included in HIV-in-pregnancy guidelines. Discuss the complete antiretroviral regimen with your HIV and obstetric specialist.

Q9: What monitoring is required during Vonaday treatment?

CD4 count and viral load every 3–6 months. Renal function (creatinine, eGFR, phosphate, urinalysis) every 6 months. Bone density assessment if osteoporosis risk factors are present.

Q10: How does Vonaday compare to FTC/TDF (Truvada equivalent)?

Both are dual NRTI backbones using Tenofovir DF. Lamivudine and Emtricitabine (FTC) are pharmacologically similar, with FTC having a slightly longer intracellular half-life. Both are clinically equivalent and interchangeable in most HIV regimens.

Q11: How should Vonaday be stored?

Store at room temperature away from light and moisture. Keep in original packaging out of reach of children.

Q12: Do I need a prescription?

Yes. Vonaday requires specialist HIV prescribing with baseline viral load, CD4, and renal function assessment, and regular monitoring throughout treatment.